Advanced but Not Localized Prostate Cancer is Associated With Increased Oxidative Stress
is accompanied by
Abstract
Purpose:
Oxidative damage has been linked to prostate carcinogenesis but its role in disease development and progression remains elusive. We investigated associations between indexes of oxidative stress with localized and advanced prostate cancer. Specifically we assessed the susceptibility of serum lipids to copper induced peroxidation (oxidizability).
Materials and Methods:
Serum oxidizability, and levels of α-tocopherol, malonyldialdehyde and uric acid were assessed in samples from 79 patients with prostate cancer, including 42 with localized and 37 with metastatic disease receiving androgen deprivation therapy, and 25 control subjects. Oxidizability was assayed by continuous spectroscopic monitoring of the accumulation of peroxidation products. The lag preceding oxidation, that is the delay between the induction and propagation of the reaction, served as a measure of the resistance of serum lipids to oxidation.
Results:
Compared to control subjects patients with localized prostate cancer had no difference in oxidative stress indexes, whereas those with metastatic disease had a shorter lag preceding oxidation and increased malonyldialdehyde (p <0.05), each reflecting a state of high oxidative stress. In patients with prostate cancer the probability of disease progression from localized to advanced state increased with a shorter lag preceding oxidation (p <0.001), increased malonyldialdehyde (p <0.03) and decreased uric acid (p <0.04). Localized and metastatic disease was associated with increased rather than decreased α-tocopherol (p <0.008 and <0.005, respectively).
Conclusions:
Patients with advanced prostate cancer are subject to high oxidative stress, as determined by increased susceptibility of serum lipids to peroxidation. This association was not detected in patients with localized cancer and it is not attributable to altered levels of α-tocopherol.
References
- 1 : Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol2004; 171: 1533. Link, Google Scholar
- 2 : Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol2004; 142: 231. Google Scholar
- 3 : Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res2004; 43: 200. Google Scholar
- 4 : Analysis of lipoprotein diene formation in human serum exposed to copper. Free Radic Res Commun1993; 19: 267. Google Scholar
- 5 : Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic Biol Med1998; 24: 607. Google Scholar
- 6 : The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments. Prog Lipid Res2002; 41: 279. Google Scholar
- 7 : Measurement of oxidizability of blood plasma. Methods Enzymol1999; 299: 35. Google Scholar
- 8 : Acute myocardial infarction is associated with increased susceptibility of serum lipids to copper-induced peroxidation in vitro. Clin Cardiol2002; 25: 63. Google Scholar
- 9 : Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol1990; 186: 407. Google Scholar
- 10 : Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer1996; 66: 145. Google Scholar
- 11 : Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res1999; 59: 1225. Medline, Google Scholar
- 12 : Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev1999; 8: 893. Google Scholar
- 13 : Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol2003; 157: 335. Google Scholar
- 14 : Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev1997; 6: 487. Google Scholar
- 15 : Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev2004; 13: 378. Google Scholar
- 16 : Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst1998; 90: 440. Crossref, Medline, Google Scholar
- 17 : Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps. Eur J Clin Nutr2002; 56: 546. Google Scholar
- 18 : Retinol and tocopherol content in primary and metastatic digestive neoplasms. Anticancer Res2003; 23: 5049. Google Scholar
- 19 : Antioxidant liposoluble vitamins and carotenoids in chronic hepatitis. Eur J Intern Med2001; 12: 116. Google Scholar
- 20 : Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology2003; 62: 849. Google Scholar
- 21 : Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst1997; 89: 40. Crossref, Medline, Google Scholar
